iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock outperforms market despite losses on the day | news.google.com • |
iBio, Inc. (NYSEAMERICAN:IBIO) Short Interest Update | news.google.com • |
iBio Inc. stock rises Friday, outperforms market | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-25 | 2024-06 | -0.46 | N/A | N/A | N/A |
2024-05-13 | 2024-03 | 0 | -0.71 | N/A | N/A |
2024-02-09 | 2023-12 | 0 | -2.42 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -4.2 | N/A | N/A |
2023-10-10 | 2023-06 | 0 | N/A | N/A | N/A |
2023-07-06 | 2023-03 | 0 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-31 | BRENNER MARTIN | Chief Executive Officer | 182.50K | Sale |
2014-09-16 | DESANTIS CARL R | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-03-30 | DURAN FELIPE | Chief Financial Officer | 39.63K | Stock Award(Grant) |
2020-08-10 | EASTERN CAPITAL LTD | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2020-06-03 | ERWIN ROBERT L | President | 108.11K | Sale |
2020-03-18 | ISETT THOMAS FRANCIS III | Chief Executive Officer | 1.27M | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 512.28K | 312.49K | 1.86% |
2023-06-29 | Avantax Planning Partners, Inc. | 155.00K | 94.55K | 0.56% |
2023-06-29 | Blackrock Inc. | 137.94K | 84.14K | 0.50% |
2023-06-29 | Bank Of New York Mellon Corporation | 87.47K | 53.36K | 0.32% |
2023-06-29 | Geode Capital Management, LLC | 76.29K | 46.53K | 0.28% |
2023-06-29 | Renaissance Technologies, LLC | 46.10K | 28.12K | 0.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 336.21K | 205.09K | 1.22% |
2023-06-29 | Vanguard Extended Market Index Fund | 165.75K | 101.11K | 0.60% |
2023-05-30 | Fidelity Extended Market Index Fund | 46.85K | 32.80K | 0.17% |
2023-05-30 | Fidelity Total Market Index Fund | 13.73K | 9.61K | 0.05% |
2023-05-30 | Fidelity Series Total Market Index Fund | 9.49K | 6.64K | 0.03% |
2023-06-29 | Vanguard Institutional Index-Inst Total Stock Market Ind | 7.28K | 4.44K | 0.03% |
Split | Date |
---|---|
1 : 20 | 2023-11-29 |
1 : 25 | 2022-10-10 |
1 : 10 | 2018-06-11 |
-
I’m in at 3.92 so if it gets close to that I’ll sell and buy back in hopefully lower.
-
-
$TNXP the cheapest CoVid 19 vaccine will run tomorrow at $3 Penny Stocks To Buy Under $4: Tonix Pharmaceuticals Holding
We talked about Tonix Pharmaceuticals Holding (TNXP Stock Report) over the weekend. This came after TNXP had one of its most active days of the year. The only other day to outpace July 17th was earlier in the year in February. Thatâ€s when the penny stock saw a move to highs of $1.23 and traded more than 167 million shares. That was when the company announced a strategic collaboration with Southern Research to support the development of a vaccine, TNX-1800 to protect against COVID-19.
This month Tonix announced that it met its target enrollment of approximately 470 participants in a Phase 3 RELIEF trial of TNX-102 SL 5.6 mg. The treatment is in development as a non-opioid, centrally acting analgesic, taken daily at bedtime for the management of fibromyalgia. On the heels of that update, Tonix also announced a collaboration with Columbia University to study immune responses against COVID-19.
“This work may also guide the selection of appropriate individuals for COVID-19 vaccine trials, such as for Tonix's TNX-1800, based on a live replicating vector platform, which is designed to confer durable T cell immunity. It is also possible that new COVID-19 vaccines can be designed which will be tailored to individuals by precision medicine,†said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. Keep in mind that the penny stock closed the week last week around $0.80 and has already started turning higher during premarket trading on Monday. Will this trend continue or is a pullback in store?
-
Do you guys thinks he was the General pointing by the President this afternoon?
General James T. Hill, USA (Ret.)
Director of IBIO
General (Ret.) James T. Hill was the Commander of the 4-Star United States Southern Command, reporting directly to the President and Secretary of Defense at the time of his retirement from active duty. As such he led all U.S. military forces and operations in Central America, South America and the Caribbean, worked directly with U.S. Ambassadors, foreign heads of state, key Washington decision-makers, foreign senior military and civilian leaders, developing and executing United States policy. His responsibilities included management, development and execution of plans and policy within the organization including programming, communications, manpower, operations, logistics and intelligence. General Hill's experience implementing plans and policies within diverse geographic regions and his insights regarding the conduct of business affairs in Central and South America is a key resource for us.
The companyâ€s subsidiary, iBio CDMO, provides FastPharming contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. Originally built in 2010 with funding from the Defense Advanced Research Projects Agency, part of the U.S. DoD, iBioâ€s FastPharming facility was part of the “Blue Angel†initiative to establish facilities capable of rapid delivery of medical countermeasures in response to a disease pandemic.
-
Do you guys thinks he was the General pointing by the President this afternoon?
General James T. Hill, USA (Ret.)
Director of IBIO
General (Ret.) James T. Hill was the Commander of the 4-Star United States Southern Command, reporting directly to the President and Secretary of Defense at the time of his retirement from active duty. As such he led all U.S. military forces and operations in Central America, South America and the Caribbean, worked directly with U.S. Ambassadors, foreign heads of state, key Washington decision-makers, foreign senior military and civilian leaders, developing and executing United States policy. His responsibilities included management, development and execution of plans and policy within the organization including programming, communications, manpower, operations, logistics and intelligence. General Hill's experience implementing plans and policies within diverse geographic regions and his insights regarding the conduct of business affairs in Central and South America is a key resource for us.
The company’s subsidiary, iBio CDMO, provides FastPharming contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. Originally built in 2010 with funding from the Defense Advanced Research Projects Agency, part of the U.S. DoD, iBio’s FastPharming facility was part of the “Blue Angel” initiative to establish facilities capable of rapid delivery of medical countermeasures in response to a disease pandemic.
-
-
Advantages of IBIO-400
Reduced Costs
Producing a subunit vaccine in plants saves time and moneyEfficacy
Studies showed protection after a single doseSafety
All vaccinated animals were protected from CSF clinical signsDIVA
Provided through the absence of Ems responseFlexibility
Potential for use in bait for feral hogs (natural virus reservoirs) without substantial purification, unlike live attenuated vaccinesAdaptability
Adaptability
Possible rapid adaptation to regional strain variations and emerging novel subgenotypes -
Holding Strong! Keep it up!
-
-
Also careful of the Washout! That would sum up your loss exponentially. Better understand the shorting. Lol
-
I hope bears still have money to chase this. Lol.
Or maybe their broker dont penalize them yet for breaking the short 3x selling the their stocks before the cash settled and available.
-
I smell Green
-
Oh boy! Oh boy! Here she comes!! Slow down please can’t press the button quick for buying!! Do it market and not limit buy!! Lol
-
Bears, watch the Green today! We need you for the Volume by the way. Just to be clear otherwise we are nit moving if No activities during the day.
-
Dump The Clutch and lets Go!
-
Where is the twat that said this wouldn’t hit 6 again lol
-
Why is thus keep going down thought they found the Vaccind that why was up last couple days could be stock manipulation by the heavy hitters...
-
-
All I knew is MRNA, AZN, Pfizer and other major Biotech company has a big meeting today. Not sure what was it but, I am guessing they will discuss IBIO for sure what’s in their plate.
-
This is nothing! You saw the PH = 7+ today you’ll see again and tomorrow PH = 7+, 8+, 9+, 10+ who knows.
-
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock outperforms market despite losses on the day
news.google.com • -
iBio, Inc. (NYSEAMERICAN:IBIO) Short Interest Update
news.google.com • -
iBio Inc. stock rises Friday, outperforms market
news.google.com • -
iBio Inc. stock rises Thursday, still underperforms market
news.google.com •